The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in revenue , its intellectual property lapse created a wave of https://pr1bookmarks.com/story21939196/viagra-and-pharma-a-risky-investment